Artificial Intelligence Collides with FDA Bureaucracy: News Article - Independent Institute

The FDA is struggling to keep up with AI innovations in healthcare and drugs, creating bureaucratic delays that slow down new treatments reaching patients. This matters because outdated regulatory rules could either block helpful AI tools or fail to catch dangerous ones.